Introduction
It has been suggested that infections may sometimes precipitate diabetes mellitus in patients in whom an underlying metabolic defect is present (Adams, 1926; Danowski, 1957) , but there is mounting evidence of the ability of certain viruses to cause diabetes by producing a pancreatitis-presumably through direct action on the insulin-forming cells.
Diabetes following foot and mouth disease has been reported in cattle, and on one occasion in a goat (Barboni and Manocchio, 1962) . Craighead and McLane (1968) described the introduction of diabetes in a proportion of mice inoculated with a neurotropic variant of encephalomyocarditis virus.
This strain induced focal lesions in the islet tissue with degranulation of the beta cells; when cortisone was given during the infection the islet tissue underwent extensive necrosis. Another strain of encephalomyocarditis virus adapted to grow in heart muscle caused necrosis of the acinar cells of infected mice but spared the islet tissue (Craighead, 1966) . The effect of virus infection on the pancreas may therefore depend both on virus variation and on host factors such as hormonal conditions. A number of viruses may cause inflammatory lesions in the pancreas without necessarily causing diabetes ; of these, Coxsackie B virus (Pappenheimer, Kunz, and Richardson, 1951) , reovirus (Stanley, Dorman, and Ponsford, 1953) , foot and mouth disease virus (Platt, 1956) , and mouse hepatitis virus (Hirano and Ruebner, 1968) affect mice, and infectious pancreatic necrosis virus affects fish (Wood, Snieszko, and Yasutake, 1955) .
In man, diabetes following mumps was reported by Stang in 1864, and others have since repeated this observation ; in some cases the appearance of diabetes has coincided with a mumps pancreatitis. Other instances of viral pancreatitis probably occur, but there is no record of their being followed by diabetes. Wislocki (1966) reported a case of infectious mono-nucleosis with pancreatitis. Coxsackie B virus infection of the newborn may induce a focal myocarditis, meningoencephalitis, and sometimes pancreatitis. Kibrick and Benirschke (1956, 1958) reported two such cases of Coxsackie B4 virus infection with necrotic lesions of the pancreas, and Fechner, Smith, and Middelkamp (1963) isolated Coxsackie B4 virus from the pancreas in another. Murphy and Simmul (1964) reported the isolation of Coxsackie B4 virus from an adult with acute pancreatitis and a rising neutralizing antibody titre to this virus during convalescence. We have seen another case, in a 28-year-old woman in whom the Coxsackie B4 neutralizing antibody titre rose from 1: 512 to 1:1,024 during the illness (Gamble, unpublished data) .
It therefore seems possible that viral infection plays some part in the aetiology of diabetes in man, particularly in juvenile cases of sudden onset. We have therefore compared antibody titres to a number of common viruses in patients with diabetes of recent onset and those in non-diabetic subjects.
Methods
During the two and a half years from January 1966 to June 1968 123 serum specimens were obtained from patients with diabetes of recent and abrupt onset at three centres (King's College Hospital, London S.E.5; Epsom District Hospital, Epsom, SuTrrey; and the General Hospital, Birmingham 4). Most of the patients showed ketosis and required insulin treatment from the outset, but at one centre (Epsom) patients with non-insulin-dependent diabetes of abrupt onset were also included.
The precise matching of controls presented difficulties, but for comparison sera were obtained from 155 patients with diabetes of more than two years' duration and from 250 healthy "controls" who had no history of active or recent infection. Table I gives details of origin of the specimens examined.
All the virological tests were done in one laboratory (Epsom). Complement fixation tests were done in plastic trays by the method of Bradstreet and Taylor (1962 The proportion positive against most of the antigens tested was similar in diabetic and control groups (Table II ). Significant differences were obtained for influenza C, para-BRITISH MEDICAL JOURNAL influenza, and Coxsackie B viruses. Influenza C and parainfluenza virus antibodies were more often present in controls than in diabetics, but it was found that the majority of positive control sera were collected from clusters of patients, and localized outbreaks of infection could therefore account for the differences found. On the other hand, there was no such explanation for the excess of diabetic patients with antibody to Coxsackie B virus who came from all areas and were not restricted to any one period of time. Control sera for this period were poorly matched, though most were deliberately collected in the first quarter of the year immediately after the enterovirus season and during the period of maximum incidence of respiratory infection. The frequent occurrence of Coxsackie B antibodies in diabetics, though inconclusive, was of interest in view of the association of Coxsackie B virus infection with pancreatitis in man and mice. Further specimens were therefore collected in 1967-8. Because of technical difficulties in the production of Coxsackie complement-fixing antigens, poor reproducibility of the tests, and lack of specificity, all subsequent tests were for neutralizing antibody only.
Coxsackie B Virus Neutralizing Antibody Titres
All serum samples were titrated for neutralizing antibodies to Coxsackie virus types B1-6. A preliminary analysis of geometric mean titres ( Fig. 1) showed that diabetics had higher titres against type B4 than normal controls, and that these titres were apparently inversely related to the duration of 
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A.-J. Some loss of information about differences between diabetics and controls was implicit in this method of correction. In those time and area groups in which there were few controls, high antibody titres of diabetics would be greatly reduced by the corrections which they themselves had largely determined. Moreover, since the mean titres of diabetics in such groups would inevitably be close to the population means, they could obscure the presence of genuine differences between antibody levels in diabetics and controls. All of the data was therefore utilized to obtain the best estimate of the corrections, but, as few controls were obtained in 1966, only data relating to specimens in 1967 and 1968 were used for the final comparison between diabetics and control& Differences were assessed by Student's i test, but the validity of this method is dependent on the data following a multivariate normal distribution. Logarithmic reciprocal antibody titres were approximately normally distributed in groups in which most titres were greater than 1: 20-the lowest dilution tested. Since negative sera had to be assigned a numerical value in calculations they were arbitrarily assumed to be positive at 1:10. This conventional assumption was essential, but it distorted distributions in groups, including many negative sera. The variance in those groups was restricted, producing a tendency towards a Poisson type of distribution. Some improvement was effected by a square root transformation, and the variable analysed was therefore the square root of the logarithm of the reciprocal antibody titre. The results are shown in Fig. 2 . Type B6 antibodies were uncommon and of low titre, and are therefore omitted. Both B max. and B4 titres were higher in all diabetics within three months of onset than in controls (P<0-01 in both instances). Antibody titres in patients seen more than three months from onset were similar to those in controls. Insudin-dependent diabetics within three months of onset also had higher B max. and B4 titres than controls (P<0-01 and P<0 02 respectively).
Non-insulin-dependent diabetics were a small group which showed no regular pattern.
Although Coxsackie virus neutralizing antibody titres persist for years they may decline more rapidly in the first few months following infection than later. The six-month period used for calculating time and area corrections might therefore be too long, and fluctuations in virus prevalence during these periods might be reflected in antibody titres. Collections of serum from both diabetics and controls were clustered in time, and minor epidemics of Coxsackie virus infection were known to have occurred. The corrected B4 and B max. titres of diabetics and controls were therefore examined during shorter calendar periods: two-month periods were used, but where numbers were small adjacent periods were combined (Fig. 3) . The titres of both groups reflected the seasonal fluctuations, but the difference between them was maintained over the whole period.
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The results for the non-insulin-dependent diabetics are irregular and inconclusive, though the high type B4 titres in those seen within three months of onset are of interest.
High mean antibody titres could result from a high proportion of sera with residual antibody due to remote infection or from a smaller proportion with high antibody titres due to recent infection. Residual titres from remote infection decline slowly, and as titres in diabetics between 3 and 12 months from onset were significantly lower than those in diabetics within three months of onset the latter presumably indicate recent infection.
There is little accurate knowledge of the maximal antibody titres attained after Coxsackie virus infection, or of their rate of decline. It is difficult, therefore, to estimate the proportion of diabetics who experienced a Coxsackie B virus infection at or before the onset of diabetes. The majority of patients with Coxsackie B virus infection develop homologous neutralizing antibody, but in a few patients antibody cannot be demonstrated or is present at very low titre (Lennette et al., 1960) . Of the 64 insulin-dependent diabetics seen within three months of onset 66%/, had antibody titres of 1: 20 or greater against Coxsackie B4 virus, compared with 400,/ % of controls. Antibody to other Coxsackie B types was found less frequently and diabetics differed little from controls. These percentages would have probably been higher had sera been tested at a lower dilution, and they suggest that a substantial proportion of these patients-but probably not all of them-had experienced Coxsackie B4 virus infection.
The results suggest, therefore, that in the small group of insulin-dependent diabetics studied there was in some cases a temporal association of Coxsackie B virus infection-probably of type B4-with the onset of diabetes. The possibility that the Coxsackie virus antibodies were induced by an antigenically related virus cannot be excluded, but it is noteworthy that a concurrent investigation (Gamble and Taylor, 1969 ) by a completely independent epidemiological approach also pointed to the possibility of an association with Coxsackie virus type B4. Furthermore, the few viruses isolated from infants with pancreatitis have almost all been Coxsackie B4 viruses. Individually these findings are not conclusive, but jointly they suggest an association which merits further investigation.
